Back to News
Market Impact: 0.2

Looking For a Crypto ETF With Upside Potential? These 3 ETFs Are Worth a Closer Look.

Source: The Motley Fool

Crypto & Digital AssetsInvestor Sentiment & PositioningTax & Tariffs

Bitcoin, Ethereum and Solana remained 33%, 46% and roughly 60%, respectively, below their 2025 all-time highs as of Sept. 29, supporting the article's case for upside in crypto ETFs. iShares Bitcoin Trust held $66.8B of net assets and cumulative inflows reached $65B by Sept. 30, while Bitwise Solana Staking ETF offered a 5.5% net reward rate. Solana staking yields are expected to decline after SIMD-0550 activates in early 2027, with baseline rewards falling from 5.8% to about 4.3% within a year and toward 2.2% by 2029.

Analysis

The relevant signal is not the promotional asset-allocation framing but the divergence in ETF-holder behavior: Bitcoin ETF ownership appears materially stickier than Ethereum exposure, which makes IBIT the cleaner institutional risk-on proxy in a rebound but also raises its vulnerability to a synchronized de-risking if macro liquidity tightens. With a dominant share of category assets, IBIT creation/redemption flows can increasingly affect authorized-participant hedging demand in CME bitcoin futures and listed crypto-equity beta (COIN, MSTR, miners), amplifying short-term correlation during large flow days.

ETHA's lack of staking yield is not automatically a disadvantage. For taxable U.S. holders, avoiding current-income treatment on rewards may improve after-tax compounding and reduces operational/regulatory uncertainty around staking. But absent yield, ETHA needs appreciation and renewed Ethereum activity to compete with staking-enabled alternatives; the likely near-term winner of Ethereum inflows is more likely a staking product, while ETHA is a tactical vehicle for investors prioritizing liquidity and tax simplicity.

BSOL's headline yield should be discounted as a return driver: lower token issuance reduces nominal distributions but can improve SOL's long-run scarcity if network demand holds. The more important 6-18 month question is whether fee generation replaces issuance as validator economics; if not, lower rewards can weaken stake participation and create sell pressure from validators. Consensus is likely underweighting this transition risk, so a high yield is not sufficient reason to own SOL beta through the issuance-change window.

No actionable read-through exists for NFLX, NVDA, or GETY. The stated impact is low and the article provides no independently verifiable evidence of incremental institutional demand, so avoid treating it as a standalone crypto catalyst.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

Key Decisions for Investors

  • Use IBIT, not COIN or MSTR, for tactical 1-3 month crypto-beta exposure; size only after confirming consecutive weekly net creations and improving CME basis. Exit on a reversal to sustained weekly redemptions or a material widening in credit spreads, which would signal liquidity-driven downside.
  • Relative-value watch: long ETHA versus short a comparable staking-enabled Ethereum vehicle only if the after-tax yield differential is smaller than implied by current reward rates and ETH ETF flows stabilize. Missing inputs are investor tax profile, fund fees, and staking-product liquidity; this is an alert, not a recommendation.
  • Avoid chasing BSOL solely for distribution yield ahead of the issuance transition. Reassess 3-6 months after activation using SOL fee revenue, validator participation, and net ETF creations; a falling reward rate without fee-growth would favor reducing SOL exposure versus BTC.
  • For liquid crypto-equity books, hedge any IBIT long with a small short COIN only if retail-volume and transaction-revenue expectations are rising faster than spot-Bitcoin flows; COIN has greater operating and multiple downside in a flat-price, low-volume environment.

More News

From AllMind Research

Browse all research